Position in GILD
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$5,463,573
-$1,915,510 QoQ
Shares Held
43,245
-18.3% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#566
of 2,275 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Tower Research Capital LLC (TRC) holds $110,167,581 across 17 Drug Manufacturers - General names. GILD ranks #6 (5.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
27,448 | $32,921,956 | |
| 2 | GSK |
GSK plc
|
463,125 | $24,277,011 | |
| 3 | NVO |
Novo Nordisk A S
|
314,106 | $15,058,240 | |
| 4 | JNJ |
Johnson & Johnson
|
38,358 | $9,741,780 | |
| 5 | ABBV |
AbbVie Inc.
|
28,379 | $7,141,291 | |
| 6 | GILD |
Gilead Sciences, Inc.
This page
|
43,245 | $5,463,573 | |
| 7 | MRK |
Merck & Co., Inc.
|
37,782 | $4,854,986 | |
| 8 | AMGN |
Amgen Inc
|
12,238 | $4,431,624 |
All Filings in GILD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,463,573 | 43,245 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $7,379,083 | 52,946 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $10,615,291 | 86,486 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $5,141,964 | 46,324 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $5,299,585 | 47,800 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $3,295,390 | 29,410 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $10,094,469 | 109,283 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $3,220,378 | 38,411 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $8,424,621 | 122,790 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $13,661,124 | 186,500 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $16,287,870 | 201,060 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $4,891,933 | 65,278 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,822,396 | 23,646 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,710,093 | 20,611 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $3,811,138 | 44,393 | Shares | Other | 2023-02-10 | |
| 2022-09-30 | $17,146,240 | 277,942 | Shares | Other | 2022-11-10 | |
| 2022-06-30 | $13,001,671 | 210,349 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $22,832,842 | 384,068 | Shares | Other | 2022-05-12 | |
| 2021-12-31 | $10,052,490 | 138,445 | Shares | Other | 2022-02-14 | |
| 2021-09-30 | $9,641,115 | 138,026 | Shares | Other | 2021-11-15 | |
| 2021-06-30 | $3,393,006 | 49,274 | Shares | Other | 2021-08-16 | |
| 2021-03-31 | $13,454,155 | 208,172 | Shares | Other | 2021-05-17 | |
| 2020-12-31 | $4,199,322 | 72,079 | Shares | Other | 2021-02-16 | |
| 2020-09-30 | $3,567,201 | 56,452 | Shares | Other | 2020-11-16 | |
| 2020-06-30 | $2,346,669 | 30,500 | Shares | Other | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||